Home / Rosuvastatin / Germany
DE ATC C10AA07 · updated 2 Nov 2026
Rosuvastatin shortage in Germany
Is there a Rosuvastatin shortage in Germany?
Yes. As of 2 Nov 2026, 13 Rosuvastatin products are reported short in Germany, the first since 6 Mar 2023. The company estimate for the return is 31 Dec 2026 (latest 31 Jul 2027). Main reason: manufacturing problem.
Also short in Canada, Italy, Spain, Ireland, Austria, Belgium, Czechia, Sweden, Japan, New Zealand, Australia. All countries.
Affected products in Germany
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| DE | ROSUVASTATIN-ELPEN 10 mg Filmtabletten | Elpen Pharmaceutical Co. Inc. Beiname: Elpen, Elpen S.A., Elpen A.E. | 6 Mar 2023 | 31 Jul 2027 | Manufacturing problem Unzureichende Produktionskapazitäten |
| DE | ROSUVASTATIN-ELPEN 10 mg Filmtabletten | Elpen Pharmaceutical Co. Inc. Beiname: Elpen, Elpen S.A., Elpen A.E. | 6 Mar 2023 | 31 Jul 2027 | Manufacturing problem Unzureichende Produktionskapazitäten |
| DE | ROSUVASTATIN-ELPEN 20 mg Filmtabletten | Elpen Pharmaceutical Co. Inc. Beiname: Elpen, Elpen S.A., Elpen A.E. | 6 Mar 2023 | 31 Jul 2027 | Manufacturing problem Unzureichende Produktionskapazitäten |
| DE | ROSUVASTATIN-ELPEN 20 mg Filmtabletten | Elpen Pharmaceutical Co. Inc. Beiname: Elpen, Elpen S.A., Elpen A.E. | 6 Mar 2023 | 31 Jul 2027 | Manufacturing problem Unzureichende Produktionskapazitäten |
| DE | ROSUVASTATIN-ELPEN 40 mg Filmtabletten | Elpen Pharmaceutical Co. Inc. Beiname: Elpen, Elpen S.A., Elpen A.E. | 6 Mar 2023 | 31 Jul 2027 | Manufacturing problem Unzureichende Produktionskapazitäten |
| DE | ROSUVASTATIN-ELPEN 5 mg Filmtabletten | Elpen Pharmaceutical Co. Inc. Beiname: Elpen, Elpen S.A., Elpen A.E. | 6 Mar 2023 | 31 Jul 2027 | Manufacturing problem Unzureichende Produktionskapazitäten |
| DE | ROSUVASTATIN-ELPEN 5 mg Filmtabletten | Elpen Pharmaceutical Co. Inc. Beiname: Elpen, Elpen S.A., Elpen A.E. | 6 Mar 2023 | 31 Jul 2027 | Manufacturing problem Unzureichende Produktionskapazitäten |
| DE | Rosuvastatin Aristo 10 mg Filmtabletten | Aristo Pharma GmbH | 24 Mar 2023 | 31 Dec 2026 | Increased demand Erhöhte Nachfrage |
| DE | Rosuvastatin Aristo 10 mg Filmtabletten | Aristo Pharma GmbH | 24 Mar 2023 | 31 Dec 2026 | Increased demand Erhöhte Nachfrage |
| DE | Rosuvastatin Aristo 20 mg Filmtabletten | Aristo Pharma GmbH | 24 Mar 2023 | 31 Dec 2026 | Increased demand Erhöhte Nachfrage |
| DE | Rosuvastatin Aristo 20 mg Filmtabletten | Aristo Pharma GmbH | 24 Mar 2023 | 31 Dec 2026 | Increased demand Erhöhte Nachfrage |
| DE | Rosuvastatin Aristo 5 mg Filmtabletten | Aristo Pharma GmbH | 24 Mar 2023 | 31 Dec 2026 | Manufacturing problem Probleme beim Sonstigen Hersteller |
| DE | Rosuvastatin Aristo 5 mg Filmtabletten | Aristo Pharma GmbH | 24 Mar 2023 | 31 Dec 2026 | Manufacturing problem Probleme beim Sonstigen Hersteller |
Source
BfArM (Federal Institute for Drugs and Medical Devices), via PharmNet.Bund. Official list. Supply-relevant medicines reported under a voluntary self-commitment; mostly hospital-relevant products.